טוען...
IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing
BACKGROUND: Isocitrate dehydrogenase 1 (IDH1) mutation is common in low-grade glioma (approximately 80%) and acute myeloid leukemia (approximately 10%). Other than brain tumor or hematologic malignancies, intrahepatic cholangiocarcinoma (iCC) is a well-known solid tumor with IDH1 mutation (6.8–20%)....
שמור ב:
| הוצא לאור ב: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5389153/ https://ncbi.nlm.nih.gov/pubmed/28403884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-017-1144-1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|